{"title":"亚什兰计划重组","authors":"None Matt Blois","doi":"10.1021/cen-10137-buscon10","DOIUrl":null,"url":null,"abstract":"The chemical firm Ashland is scaling back production of the food and cosmetic ingredients carboxymethyl cellulose, methyl cellulose, and hydroxyethyl cellulose in response to low demand. The company also plans to sell its nutraceuticals business. Ashland recently announced that it will focus on industries in which it has the biggest technology advantage, such as ingredients for pharmaceuticals, personal care products, and coatings. The firm sold its adhesives business to Arkema for $1.65 billion in 2022 .","PeriodicalId":9517,"journal":{"name":"C&EN Global Enterprise","volume":"29 16","pages":"0"},"PeriodicalIF":0.0000,"publicationDate":"2023-11-13","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Ashland plans restructuring\",\"authors\":\"None Matt Blois\",\"doi\":\"10.1021/cen-10137-buscon10\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"The chemical firm Ashland is scaling back production of the food and cosmetic ingredients carboxymethyl cellulose, methyl cellulose, and hydroxyethyl cellulose in response to low demand. The company also plans to sell its nutraceuticals business. Ashland recently announced that it will focus on industries in which it has the biggest technology advantage, such as ingredients for pharmaceuticals, personal care products, and coatings. The firm sold its adhesives business to Arkema for $1.65 billion in 2022 .\",\"PeriodicalId\":9517,\"journal\":{\"name\":\"C&EN Global Enterprise\",\"volume\":\"29 16\",\"pages\":\"0\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2023-11-13\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"C&EN Global Enterprise\",\"FirstCategoryId\":\"1085\",\"ListUrlMain\":\"https://doi.org/10.1021/cen-10137-buscon10\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"C&EN Global Enterprise","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1021/cen-10137-buscon10","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
The chemical firm Ashland is scaling back production of the food and cosmetic ingredients carboxymethyl cellulose, methyl cellulose, and hydroxyethyl cellulose in response to low demand. The company also plans to sell its nutraceuticals business. Ashland recently announced that it will focus on industries in which it has the biggest technology advantage, such as ingredients for pharmaceuticals, personal care products, and coatings. The firm sold its adhesives business to Arkema for $1.65 billion in 2022 .
京公网安备 11010802042870号
京ICP备2023020795号-1
分享
求助内容：
应助结果提醒方式：
扫码关注我们
